rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1999-8-11
|
pubmed:abstractText |
In vitro studies have shown that the 30 and 69 base pair (bp) deletion variants of the latent membrane protein (LMP)-1 gene of the Epstein-Barr virus (EBV) have a higher transforming capacity than the wild-type variant. In recent years these studies have triggered an in vivo search for such potentially oncogenic variants in lymphoid tissues.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
467-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10370791-Biopsy,
pubmed-meshheading:10370791-Gene Deletion,
pubmed-meshheading:10370791-Gene Frequency,
pubmed-meshheading:10370791-HIV Seronegativity,
pubmed-meshheading:10370791-Herpesvirus 4, Human,
pubmed-meshheading:10370791-Humans,
pubmed-meshheading:10370791-Lymph Nodes,
pubmed-meshheading:10370791-Lymphoproliferative Disorders,
pubmed-meshheading:10370791-Membrane Proteins,
pubmed-meshheading:10370791-Oncogene Proteins, Viral,
pubmed-meshheading:10370791-Polymerase Chain Reaction,
pubmed-meshheading:10370791-Sensitivity and Specificity
|
pubmed:year |
1999
|
pubmed:articleTitle |
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign.
|
pubmed:affiliation |
Department of Medical Sciences, University of Modena, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|